215 related articles for article (PubMed ID: 27629732)
1. Adiponectin and Cardiac Hypertrophy in Acromegaly.
Gurbulak S; Akin F; Yerlikaya E; Yaylali GF; Topsakal S; Tanriverdi H; Akdag B; Kaptanoglu B
Adv Clin Exp Med; 2016; 25(3):449-55. PubMed ID: 27629732
[TBL] [Abstract][Full Text] [Related]
2. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.
Silha JV; Krsek M; Hana V; Marek J; Jezkova J; Weiss V; Murphy LJ
Clin Endocrinol (Oxf); 2003 Jun; 58(6):736-42. PubMed ID: 12780751
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
[TBL] [Abstract][Full Text] [Related]
4. [Serum adiponectin levels in patients with acromegaly].
Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
[TBL] [Abstract][Full Text] [Related]
5. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess.
Lam KS; Xu A; Tan KC; Wong LC; Tiu SC; Tam S
J Clin Endocrinol Metab; 2004 Nov; 89(11):5448-53. PubMed ID: 15531496
[TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
[TBL] [Abstract][Full Text] [Related]
7. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
[TBL] [Abstract][Full Text] [Related]
8. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
[TBL] [Abstract][Full Text] [Related]
9. Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.
Ronchi CL; Corbetta S; Cappiello V; Morpurgo PS; Giavoli C; Beck-Peccoz P; Arosio M; Spada A
Eur J Endocrinol; 2004 May; 150(5):663-9. PubMed ID: 15132722
[TBL] [Abstract][Full Text] [Related]
10. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
11. Resistin and leptin levels in acromegaly: lack of correlation with echocardiographic findings.
Gurbulak S; Yaylali GF; Yerlikaya E; Akin F; Topsakal S; Tanrverdi H; Akdag B; Aslan AR
J Investig Med; 2013 Mar; 61(3):582-5. PubMed ID: 23360845
[TBL] [Abstract][Full Text] [Related]
12. Cardiac effect of thyrotoxicosis in acromegaly.
Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
[TBL] [Abstract][Full Text] [Related]
13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
14. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
15. Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values.
Pietrobelli DJ; Akopian M; Olivieri AO; Renauld A; Garrido D; Artese R; Feldstein CA
J Hum Hypertens; 2001 Sep; 15(9):601-5. PubMed ID: 11550105
[TBL] [Abstract][Full Text] [Related]
16. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
[TBL] [Abstract][Full Text] [Related]
18. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
[TBL] [Abstract][Full Text] [Related]
20. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
